Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial

Originalspråk	engelska
Tidskrift	Alimentary Pharmacology and Therapeutics
DOI	https://doi.org/10.1111/apt.17073
Status	Published - 2022 juni 24

Ämnesklassifikation (UKÄ)

@article{5213fe7d47004014b325f652d34463e8,

title = "Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply",

author = "Viktoria Bergqvist and Johanna Holmgren and Daniel Klintman and Jan Marsal",

year = "2022",

month = jun,

day = "24",

doi = "10.1111/apt.17073",

language = "English",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "1365-2036",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply

AU - Bergqvist, Viktoria

AU - Holmgren, Johanna

AU - Klintman, Daniel

AU - Marsal, Jan

PY - 2022/6/24

Y1 - 2022/6/24

U2 - 10.1111/apt.17073

DO - 10.1111/apt.17073

M3 - Debate/Note/Editorial

C2 - 35748834

SN - 1365-2036

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

ER -